HKU Scholars Hub: Browsing DSpace

Browsing by Author Honeycutt, W

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 5 of 5

	Title	Author(s)	Issue Date
	A phase II study of oxaliplatin, dose-intense capecitabine, and high-dose bevacizumab in the treatment of metastatic colorectal cancer Journal:Clinical Colorectal Cancer	Wong, NS Fernando, NH Bendell, JC Morse, MA Blobe, GC Honeycutt, W Pang, H Hurwitz, HI	2011
	A phase II trial of bevacizumab plus everolimus for patients with refractory metastatic colorectal cancer Journal:Oncologist	Altomare, I Bendell, JC Bullock, KE Uronis, HE Morse, MA Hsu, SD Zafar, SY Blobe, GC Pang, H Honeycutt, W Sutton, L Hurwitz, HI	2011
	Biomarker Signatures Correlate with Clinical Outcome in Refractory Metastatic Colorectal Cancer Patients Receiving Bevacizumab and Everolimus Journal:Molecular Cancer Therapeutics	Liu, Y Starr, M Brady, J Rushing, C Bulusu, A Pang, HMH Honeycutt, W Amara, A Altomare, I Uronis, H	2015
	Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab Journal:Cancer Medicine	Liu, Y Starr, MD Bulusu, A Pang, HMH Wong, NS Honeycutt, W Amara, A Hurwitz, HI Nixon, AB	2013
	Use of plasma angiome to predict PFS in patients with metastatic colorectal cancer (mCRC) treated with capecitabine, oxaliplatin, and bevacizumab (XELOX-A) Proceeding/Conference:Journal of Clinical Oncology	Nixon, A Starr, M Pang, HMH Bulusu, A Honeycutt, W Amara, A Bendell, JC Hurwitz, H	2010

Showing results 1 to 5 of 5